CGRP mechanism antagonists and migraine management

Current Neurology and Neuroscience Reports
Nazia Karsan, P J Goadsby

Abstract

Migraine is a complex disorder of the brain that is common and highly disabling. As understanding of the neural pathways has advanced, and it has become clear that the vascular hypothesis does not explain the disorder, new therapeutic avenues have arisen. One such target is calcitonin gene-related peptide (CGRP)-based mechanisms. CGRP is found within the trigeminovascular nociceptive system widely from the trigeminal ganglion to second-order and third-order neurons and in regulatory areas in the brainstem. Studies have shown CGRP is released during severe migraine attacks and the reversal of the attack with effective triptan treatment normalizes those levels. CGRP administration triggers migraine in patients, and CGRP receptor antagonists have been shown to abort migraine. Here, we review the current state of CGRP mechanism antagonist therapy as its research and development is increasing in migraine therapeutics. We discuss several recent trials, highlighting the evidence base behind these novel drugs, and their potential future contribution to migraine management.

References

Dec 1, 1987·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·L EdvinssonR Uddman
Jul 1, 1995·Canadian Journal of Physiology and Pharmacology·G FeuersteinN Aiyar
Mar 11, 2000·British Journal of Pharmacology·H DoodsW Eberlein
Apr 11, 2001·Lancet·A BahraP J Goadsby
Feb 16, 2002·The Journal of Biological Chemistry·John J MalleeStefanie A Kane
Mar 12, 2004·The New England Journal of Medicine·Jes OlesenUNKNOWN BIBN 4096 BS Clinical Proof of Concept Study Group
May 19, 2004·Headache·David DodickUNKNOWN Triptan Cardiovascular Safety Expert Panel
Jan 22, 2005·Cephalalgia : an International Journal of Headache·K A PetersenJ Olesen
Feb 12, 2005·Brain : a Journal of Neurology·S K AfridiP J Goadsby
May 11, 2005·Neuroscience Letters·Stefan JustHenri Doods
Feb 4, 2006·Current Drug Metabolism·A Baumann
Dec 5, 2006·Trends in Molecular Medicine·Peter J Goadsby
Jan 31, 2007·Neurology·R B LiptonUNKNOWN AMPP Advisory Group
Sep 9, 2008·British Journal of Pharmacology·L Edvinsson
Jan 22, 2009·The Cerebellum·Filippo BrighinaBrigida Fierro
Jun 30, 2009·Neuroscience·P StrataO P Ottersen
Jan 12, 2010·MAbs·Jacques Descotes
Feb 23, 2010·Lancet Neurology·Peter J Goadsby, Till Sprenger
Mar 17, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Till Sprenger, Peter J Goadsby
Apr 27, 2010·Lancet·Lars Edvinsson, Mattias Linde
Sep 8, 2010·Nature Reviews. Neurology·Tony W HoPeter J Goadsby
Sep 22, 2010·Cephalalgia : an International Journal of Headache·Jakob Møller HansenMessoud Ashina
Oct 27, 2010·Cephalalgia : an International Journal of Headache·Andrew P HoTony W Ho
Dec 22, 2010·Cephalalgia : an International Journal of Headache·Hans-Christoph DienerJana Podhorna
Dec 24, 2010·Therapeutic Advances in Neurological Disorders·Sajedeh Eftekhari, Lars Edvinsson
Mar 9, 2011·Cephalalgia : an International Journal of Headache·David J HewittTony W Ho

❮ Previous
Next ❯

Citations

Sep 17, 2016·Journal of Neuropathology and Experimental Neurology·Matthew S YorekMark A Yorek
Mar 10, 2016·Cephalalgia : an International Journal of Headache·K IbrahimiA MaassenVanDenBrink
Jun 26, 2017·Current Pain and Headache Reports·N KarsanP J Goadsby
Oct 11, 2017·Antioxidants & Redox Signaling·Patrizia FerroniFiorella Guadagni
Oct 5, 2017·British Journal of Pharmacology·Tahlia Sundrum, Christopher S Walker
Nov 7, 2017·Cephalalgia : an International Journal of Headache·Angela J OkraglyRobert J Benschop
Nov 12, 2015·BMC Medicine·Dimos D Mitsikostas, Alan M Rapoport
Oct 24, 2017·British Journal of Pharmacology·Debbie L HayChristopher S Walker
Nov 17, 2017·Naunyn-Schmiedeberg's Archives of Pharmacology·Michele Viana, Shazia Afridi
Apr 5, 2017·Frontiers in Neurology·Charles Stevens Leger, Joseph F X DeSouza
Dec 24, 2018·Obstetric Medicine·Shazia K Afridi
Aug 5, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Chung-Chih LiaoChing-Liang Hsieh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Neurology
Nazia Karsan, P J Goadsby
Nihon rinsho. Japanese journal of clinical medicine
Shu-ichi Kojima, Yuichiro Kamikawa
Therapeutic Advances in Neurological Disorders
Sajedeh Eftekhari, Lars Edvinsson
Expert Opinion on Investigational Drugs
Michael J M Fischer
Progress in Medicinal Chemistry
Theresa M WilliamsChristopher A Salvatore
© 2021 Meta ULC. All rights reserved